Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...

Scientists have discovered that earwax may hold clues to early Parkinson's detection. Analyzing volatile organic compounds ...

Scientists from the University of Copenhagen have uncovered a critical clue about what causes Parkinson’s disease, offering ...

Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic mutation.

While the research is still in early stages, it’s an exciting step forward. Most current treatments for Parkinson’s only help ...

A groundbreaking study suggests that Parkinson’s disease may begin in the kidneys, where a toxic protein builds up and ...

Researchers reported that the AI model could accurately distinguish between individuals with and without Parkinson's based on ...

Scientists have achieved a major breakthrough in Parkinson's disease research, identifying a brain protein that may unlock new possibilities for treatment, a new research has revealed.